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https://doi.org/10.1016/j.celrep.2021.109352SUMMARYBone stroma contributes to the regulation of osteogenesis and hematopoiesis but also to fracture healing
and disease processes. Mesenchymal stromal cells from bone (BMSCs) represent a heterogenous mixture
of different subpopulations with distinct molecular and functional properties. The lineage relationship be-
tween BMSC subsets and their regulation by intrinsic and extrinsic factors are not well understood. Here,
we show with mouse genetics, ex vivo cell differentiation assays, and transcriptional profiling that BMSCs
from metaphysis (mpMSCs) and diaphysis (dpMSCs) are fundamentally distinct. Fate-tracking experiments
and single-cell RNA sequencing indicate that bone-forming osteoblast lineage cells and dpMSCs, including
leptin receptor-positive (LepR+) reticular cells in bone marrow, emerge from mpMSCs in the postnatal meta-
physis. Finally, we show that BMSC fate is controlled by platelet-derived growth factor receptor b (PDGFRb)
signaling and the transcription factor Jun-B. The sum of our findings improves our understanding of BMSC
development, lineage relationships, and differentiation.INTRODUCTION
Developmental growth of the skeletal system involves extensive
communication between different stromal cell types, including
mesenchymal stem/progenitor cells, committed osteoblast line-
age cells, mature osteocytes, chondrocytes, vascular cells, and
bone-degrading osteoclasts (Bianco et al., 2008, 2014; Cook
and Genever, 2013; Olsen et al., 2000). Some of these interac-
tions persist after the completion of developmental bone forma-
tion and remain relevant in the context of lifelong hematopoiesis,
homeostasis of the skeletal system, fracture healing, or osteopo-
rotic bone loss (Gerber and Ferrara, 2000; Maes and Clemens,
2014; Sacchetti et al., 2007; Sivaraj and Adams, 2016; Zelzer
and Olsen, 2005). BMSCs are a heterogenous mixture of
different cell subpopulations, which are often associated with
progenitor properties, colony-forming capacity ex vivo, and the
potential to generate bone, cartilage, fat, fibroblasts, and
vascular support cells (i.e., pericytes and vascular smooth mus-
cle cells) (Bianco et al., 2008; Nombela-Arrieta et al., 2011; Orti-
nau et al., 2019; Zhou et al., 2014). Some key features are not
shared by all BMSCs and, instead, are probably confined to
comparably rare mesenchymal stem and progenitor cells
(MSPCs) or skeletal stem cells (SSCs), which are characterized
by self-renewal capacity and multipotency, i.e., the ability to
give rise to multiple differentiated cell types in a clonal fashion
(Bianco et al., 2008; Nombela-Arrieta et al., 2011; Ono et al.,
2019; Sacchetti et al., 2007; Uccelli et al., 2008). SSCs existThis is an open access article under the CC BY-Nwithin the growth plate or periosteum in early long-bone devel-
opment but have been also been found in adult periosteum
and bone marrow (BM) (Chan et al., 2015, 2018; Debnath
et al., 2018; Mizuhashi et al., 2018; Ono et al., 2019; Ortinau
et al., 2019). Another important BMSC subpopulation is
CXCL12-abundant reticular (CAR) cells, which are similar or
identical to leptin receptor-positive (LepR+) cells, are tightly
associated with the sinusoidal BM vasculature, and function as
critical regulators of hematopoiesis (Ding et al., 2012; Sugiyama
et al., 2006). LepR+ cells can also give rise to osteoblast lineage
cells and have been implicated in bone formation (Ding et al.,
2012; Zhou et al., 2014). LepR+ BMSCs include cells that ex-
press markers of stem cells and neurons, namely Thy (CD90)
and Nestin (Isern et al., 2014; Méndez-Ferrer et al., 2010; Worth-
ley et al., 2015). Expression of the markers Gremlin 1 and CD105
labels a population of reticular SSCs, which can give rise to
chondrocytes, osteoblasts, and BM perivascular stromal cells
(Worthley et al., 2015). SSCs/MSPCs were also reported to ex-
press the receptor kinase PDGFRb, which, in response to activa-
tion by platelet-derived growth factor B (PDGF-B), promotes
bone formation and regeneration (Böhm et al., 2019; Xie et al.,
2014).
Recently, single-cell RNA sequencing (scRNA-seq) has pro-
vided further insight into the heterogeneity of BMSCs in healthy
adults and challenged mice (Addo et al., 2019; Baccin et al.,
2020; Baryawno et al., 2019; Tikhonova et al., 2019; Wolock
et al., 2019; Zhong et al., 2020). Although these studies have ledCell Reports 36, 109352, July 13, 2021 ª 2021 The Authors. 1
C-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
Figure 1. Characterization and heterogeneity of BMSCs
(A and B) Tile-scan confocal images of 3-week-old Pdgfra-GFP (green) femur in a longitudinal section (A) and transverse section through diaphysis (B), immu-
nostained for PDGFRb (red) and the EC marker EMCN (blue). Epiphysis (epi), metaphysis (mp), growth plate (gp), cortical bone (cb), bone marrow (bm), central
vein (cv; white arrowheads), and arteries (a; yellow arrowheads) are indicated. Dashed lines illustrate borders of growth plate and metaphysis. White arrowheads
(legend continued on next page)






OPEN ACCESSto the identificationof numerousBMSCsubsets, the spatial distri-
bution, lineagespecification, and functional rolesofmanyof these
populations remain to be determined. In addition, little is known
about BMSC heterogeneity in the context of bone growth and
development. Here, we provide insight into the properties of
BMSCs in developing long bone with a combination of bulk and
scRNA-seq, ex vivo colony formation assays, genetic fate
tracking in postnatal mice, and gene inactivation experiments.
The sum of our work indicates that metaphyseal BMSCs (i.e.,
mpMSCs) possess growth and multipotential differentiation po-
tential that is not shared by diaphyseal dpMSCs from theBMcav-
ity. PDGF-B functions as a BMSC niche factor, which promotes
osteogenic differentiation and represses adipogenesis. Finally,
weshow that lossof theAP-1 family transcription factor Jun-B im-
pairs the osteogenic differentiation capacity of BMSCs and
thereby enhances adipogenesis during skeletal development.
RESULTS
Distribution and features of BMSCs in long bone
To study the spatial distribution andmorphology ofmesenchymal
stromal cells during postnatal bone growth at single-cell resolu-
tion, we analyzed the femurs of 3-week-old Pdgfra-H2BGFP
(Pdgfra-GFP) knock-in reporter mice, which express nuclear
green fluorescent protein (GFP) in PDGFRa+ cells (Hamilton
et al., 2003) by immunostaining. In themetaphysis (mp), the region
mediating the growth of long bone, Pdgfra-GFP labels cells in
trabecular bone (tb) and compact bone (cb) but also a subset of
growth-plate chondrocytes. Although Pdgfra-GFP+ cells lack
PDGFRb immunosignal in cb and cartilage, double-positive cells
(PDGFRa+b+) are located around blood vessels in mp, BM, and
epiphysis (Figures 1A, 1B, S1A, and S1B). These perivascular,
PDGFRb+ BMSCs express comparably low levels of Pdgfra-
GFPboth inmpanddiaphysis (Figures 1CandS1B).Co-immuno-
staining for osterix (OSX) shows low levels of the nuclear
transcription factor in a fraction of vessel-associatedPDGFRa+b+
cells, whereas high OSX signal identifies PDGFRa+b osteopro-
genitor cells (OPCs) in themp and endosteum lining the inner sur-
face of cb (Figures 1D, 1E, S1C, and S1D). Differentiated bone
cells in compact and trabecular bone are also PDGFRa+b but
lack OSX expression (Figures 1F, 1G, S1E, and S1F). Using a ge-indicate Pdgfra-GFP+ PDGFRb+ double-positive cells in metaphysis, bone marr
PDGFRb cells, including osteocytes in cortical and trabecular bone as well as c
(C) Representative maximum intensity projections and optical z stack single plane
in PDGFRb (red) perivascular cells (arrowheads). (Right) Higher magnification of
(D) Confocal image showing Osterix+ (OSX, gray) osteoprogenitor cells together
Pdgfra-GFP double-positive cells are marked by arrowheads, whereas cells w
magnification image on the right highlights Pdgfra-GFP+ PDGFRb+ OSX+ triple-p
(E) Quantification of Pdgfra-GFP+ PDGFRb+ double-positive cells and Pdgfra-GF
higher in single-positive cells compared with Pdgfra+b+ cells. (n = 5–8; data are p
(F and G) High-magnification confocal images of Pdgfra-GFP (green) femoral d
endosteum (eo) next to cortical bone (cb) and marrow, PDGFRb+ cells co-expres
express OSX+ (red) (G).
(H) Representative image of perivascular (arrowheads) Pdgfra-GFP+ PDGFRb+ B
(RUNX2) (red). ECs, EMCN (blue).
(I and J) Electron micrographs of 3-week-old wild-type metaphysis (I) and marrow
and osteoblasts (OB). Collagen bundle in metaphysis and thin fiber structures in
See also Figure S1 and S2netic reporter for OSX expression, Sp7-mCherry, in combination
with Pdgfra-GFP, we confirm the presence of double-positive
cells in trabecular and cb but also in epiphysis (Figures S1G and
S1H). Although OSX is low or absent in vessel-associated
PDGFRa+b+ BMSCs in the mp, those cells express RUNX2, a
transcription factor marking immature osteoblast-lineage cells
(Figures 1G and 1H). Larger arteries in the BM are covered by
PDGFRa+b+ cells, which represent vascular smooth muscle cells
(SMCs) and show expression of a-smooth muscle actin (a-SMA)
and the proteoglycan Cspg4/NG2 (Figures S1I and S1J). In
contrast, reticular cells associated with sinusoidal vessels in the
BM are PDGFRa+b+ but lack appreciable NG2 and a-SMA
expression and extend long matrix fibers containing collagen
IIIA1 and IV (Figures S2A and S2B). Ultrastructural analysis con-
firms that mesenchymal stromal cells in BM are associated with
thin reticular fibers, whereas thick collagen bundles are abundant
in the mp (Figures 1I and 1J). The analysis of Ki67, a marker of
proliferating cells, reveals further differences among PDGFRa+b+
cell populations, which showmuch higher Ki67 labeling in themp
than in the diaphysis (Figure S1K).
The data above are consistent with substantial heterogeneity
among BMSCs and indicate fundamental differences between
the diaphyseal (dpMSC) and metaphyseal (mpMSC) BMSC sub-
populations. Furthermore, expression of Hairy/enhancer-of-split
related with YRPW motif protein 1 (Hey1), a Notch-pathway
component, which we detected with a Hey1-GFP reporter allele,
prominently labelsmpMSCs but is absent in dpMSCs (Figures 2A
and S2C). To gain insight into the molecular signatures of
PDGFRa+b+Hey1+ mpMSCs and PDGFRa+b+Hey1 dpMSCs,
we used flow cytometry to sort those cell populations from 3-
week-old Pdgfra-GFP+ orHey1-GFP+ reporter mice (seeMethod
details) (Figure S2D) for bulkRNA-seq. Principle component anal-
ysis (PCA) of the resulting RNA-seq data shows low variation
within each sample group but major differences (PC1, 56%) be-
tween mpMSCs and dpMSCs (Figures 2B and S2E): 2,044 tran-
scripts are upregulated and 1,686 downregulated in mpMSCs
compared with dpMSCs (Figures 2C and S2F). Numerous
BMSC markers and, as gene ontology analysis reveals, genes
associated with vascular and skeletal development are enriched
in mpMSCs relative to dpMSCs (Figures 2D, S2G, and S2H).
When mpMSCs and dpMSCs are isolated and cultured in vitro,ow, growth plate, and epiphysis, whereas white arrows point at Pdgfra-GFP+
hondrocytes in the growth plate and articular cartilage (top).
(center) of metaphyseal region showing Pdgfra-GFP (green, arrow) expression
vessel with lumen (lu) lined by EMCN+ (blue) ECs.
with Pdgfra-GFP (green) and PDGFRb (red) staining in metaphysis. OSX+ and
ith only Pdgfra-GFP+ signal are shown by arrows. ECs, EMCN+ (blue). High-
ositive cells (yellow arrowhead).
P+ PDGFRb cells in metaphysis. Pdgfra-GFP expression (mean intensity) is
resented as means ± SEM, p values, two-tailed unpaired t test).
iaphysis and marrow immunostained for PDGFRb (red) and EMCN (blue). In
s Pdgfra-GFP, whereas Pdgfra-GFP+ cells in periosteum lack PDGFRb (F) but
MSCs in metaphysis and BM co-expressing Runt-related transcription factor 2
(J). Arrows highlight ECs, perivascular MSCs (PVC), hematopoietic cells (HC),
BM (yellow arrowheads) are indicated in high-magnification images.
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Figure 2. Properties of metaphyseal BMSCs
(A) Hey1-GFP (green) expression in 3-week-old femur is predominantly found in metaphysis. GFP co-localizes with PDGFRb (red, left) and PDGFRa (red, right) in
the metaphysis (arrowheads) but also labels arterial ECs (arrow) in BM. ECs, EMCN+ (blue).
(B) Principal component analysis (PCA) of RNA sequencing data shows 56% variance (PC1) between sorted mpMSCs and dpMSCs and 17% variance (PC2)
within sample groups.
(legend continued on next page)






OPEN ACCESSthe former population has significantly greater potential to
generate colonies and can readily form spheroid-like structures
consisting of PDGFRa+b+ cells (Figures 2E, 2F, and S2I). Further-
more, mpMSCs can be efficiently differentiated to osteogenic,
adipogenic, and chondrogenic lineage cells in vitro (Figures 2G–
2J). These data indicate that mpMSCs have multipotent proper-
ties, whereas dpMSCs showed only limited growth in vitro under
thesameconditions, precludingexvivocell differentiationassays.
BMSC expansion and lineage-specific differentiation
Next,weusedgenetic approaches tostudyBMSCexpansionand
lineage-specific differentiation in bone development in vivo.
BMSC populations were genetically labeled with a range of
tamoxifen-inducible Cre alleles, namelyPdgfrb-CreERT2 (Walker
et al., 2019), Lepr-CreERT2 (see Method details), Gli1-CreERT2
(Ahn and Joyner, 2004), and Myh11-CreERT2 (Wirth et al.,
2008), in combination with the Rosa26-mTmG Cre reporter (Mu-
zumdar et al., 2007). For fate tracking analysis, pups received
tamoxifen from P1–P3 and were analyzed at P4 and P21. In
another series of experiments, tamoxifen was given at P22–
P24, followed by analysis at P27 and 8 weeks (Figure 3A). At P4,
Pdgfrb-CreERT2-labeled GFP+ cells represent predominantly
mpMSCs in the mp, cells in the periosteum covering the outer
bone surface, and isolated growth-plate chondrocytes (Fig-
ure 3B). These freshly labeled GFP+ cells show the expected
PDGFRb immunosignal but lack staining for OSX, the cartilage-
specific proteoglycan core protein aggrecan or the adipocyte
marker perilipin (Figure S3A). By P21, GFP+ cells have substan-
tially expanded throughout the femur and include very different
cell subpopulations, including OSX+ osteoprogenitors, aggre-
can+ chondrocytes, perilipin+ adipocytes, and highly branched
reticular cells in BM (Figures 3B, 3D, and S3B). Similarly, after
tamoxifen administration to juvenile mice (P22–P24), femurs
showed strong expansion of GFP+ cells in mp andBMat 8weeks
relative to P27, whereas chondroprogenitor cells in the growth
plate were no longer labeled by Pdgfrb-CreERT2 (Figure 3C).
Next, we generated tamoxifen-inducible Lepr-CreERT2 trans-
genic mice (see Method details) to target LepR+ cells, which
have been previously associated with bone formation (Zhou
et al., 2014) (Figure S3C). After tamoxifen administration from
P1–P3, Lepr-CreERT2-labeled GFP+ cells represented predomi-
nantly mpMSCs in the mp at P4 but show substantial expansion(C) Differentially regulated genes in MA plots of mpMSCs relative to dpMSCs. The
change between the two populations. Differentially regulated genes are represe
absolute log2-fold change < 1). Data points outside of the range of the y axis are
(D) Heatmap of differentially expressed BMSC marker genes in mpMSCs and BM
(E) Quantification of colony-forming units (CFU) in mpMSCs compared with dpMS
test).
(F) Confocal image of spheroid formed by Pdgfra-GFP+ PDGFRb+ mpMSCs after
right.
(G and H) Osteogenic cells derived from mpMSCs in culture express the osteob
Upregulation of osteogenic markers in differentiated cells relative to mpMSCs (H
test).
(I) Adipogenic differentiation of mpMSCs in culture indicated by perilipin immunos
relative to control (n = 4; data are presented as mean ± SEM, p values, two-taile
(J) Chondrogenic differentiation of cultured mpMSCs indicated by Aggrecan imm
relative to control (n = 4; data are presented as mean ± SEM, p values, two-taile
See also Figure S2into the BM and differentiation into OPCs and reticular cells by
P21 (Figures 3E, 3F, and S3D). Likewise, the late tamoxifen
administration regime (P22–P24) labels mpMSCs in the mp at
P27, which is followed by expansion of GFP+ cells into the BM
cavity in the following 5 weeks (Figure 3G). Like Pdgfrb-CreERT2
and Lepr-Cre-ERT2, Gli1-Cre-ERT2, which has been previously
been used to mark osteogenic progenitors (Shi et al., 2017), tar-
gets mpMSCs at P21, which later differentiated into OSX+
OPCs or expanded into the BM cavity (Figures S3E and S3F).
All three mouse lines tested above consistently indicated that
mpMSCs from the mp included progenitors, which proliferate
substantially and give rise to other cell types in bone andmarrow.
By contrast, genetic labeling and tracking of PDGFRa+b+ SMCs
covering arterieswithMyh11-CreERT2did not result in expansion
or fate changes of GFP+ cells, indicating that this cell population
lacks appreciable progenitor capacity (Figure S3G). Thus,
PDGFRa+b+ subpopulations have distinct properties and differ-
entiation potential under physiological conditions. Vascular
SMCs are firmly restricted to the coverage of arteries, whereas
vessel-associated mpMSCs undergo substantial expansion and
give rise to OPCs and reticular cells in BM. This developmental
hierarchy is directly supported by genetic fate tracking with
tamoxifen-inducible Pdgfrb-CreERT2, Lepr-CreERT2, and Gli1-
CreERT2 mice. Constitutive Lepr-Cre (DeFalco et al., 2001)
mice label both mpMSCs and dpMSCs in the postnatal femur
(Figures S4A–S4E), which is, even in the absence of temporally
controlled cell labeling, consistent with the emergence of
dpMSCs from mpMSCs presented above.
In adult (12-week-old) postnatal long bone, the number of
OSX+ osteoprogenitors is significantly reduced relative to juve-
nile (3-week-old) samples (Figure 3H) (Kusumbe et al., 2014).
Another age-related change is the increased appearance of ad-
ipocytes in the adult transition zone, i.e., the region at the inter-
face of mp and BM, compared with juvenile bone (Figure 3I). In
response to gamma-irradiation (9 Gy), adult long bones become
filled with Perilipin+ adipocytes both in mp and BM cavity (Fig-
ures 3J and S4F). Genetic lineage tracing indicates that these
adipocytes are derived from Pdgfrb-CreERT2-labeled (GFP+)
stromal cells or their progeny (Figure S4G).
Overall, these data show that PDGFRa+b+mpMSCs can differ-
entiate into multiple lineages, including dpMSCs in BM, during
bone development. In the adult organism, mpMSC-derivedx axis represents mean normalized counts, and the y axis shows the log2-fold
nted by red-colored points (false-detection rate [FDR]-adjusted p < 0.01 and
represented as triangles.
-derived dpMSCs.
Cs. (n = 6; data are presented as mean ± SEM, p values, two-tailed unpaired t
15–20 days in culture. Inset marks spheroid shown at high magnification on the
last lineage markers osteopontin (OPN, blue) and osteocalcin (OCN, red) (G).
) (n = 4–8; data are presented as mean ± SEM, p values, two-tailed unpaired t
taining (left) and significantly increased transcription of Adipoq,Cfd, and Pparg
d unpaired t test).
unostaining (left) and significantly increased transcription of Acan and Col11a2
d unpaired t test).
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Figure 3. mpMSC expansion and differentiation in postnatal bone in vivo
(A) Scheme showing CreERT2-mediated recombination of R26-mT/mG Cre reporter for lineage tracing. Tamoxifen was administered at P1–P3 for analysis at P4
and P21 or at P22–P24 for analysis at P27 and 8 weeks, respectively.
(B andC) Tile scan confocal image ofPdgfrb-CreERT2 R26-mT/mG femurs. Mice received tamoxifen at P1–P3 or P22–P24 for analysis at P4 and P21 (B) or at P27
and 8 weeks (C), respectively. Yellow arrowheads mark GFP+ chondrocytes in growth plate, white arrowheads GFP+ cells in metaphysis, and bone marrow.
(D) Representative confocal images of 3-week-old Pdgfrb-CreERT2 R26-mT/mG femur showing differentiation of GFP+ (green) cells into OSX+ osteoprogenitors
(top), ACAN+ chondrocytes (center), and PLIN+ adipocytes (bottom).
(legend continued on next page)






OPEN ACCESSBMSCs retain plasticity and can undergo adipogenic specifica-
tion in response to stress.
Transcriptional landscape and heterogeneity of BMSCs
at single-cell resolution
To identify cellular heterogeneity and molecular signatures of
non-hematopoietic cells in bone, we used microbeads contain-
ing lineage cocktail, CD45, and CD117 (c-Kit) antibodies (see
Method details) to deplete hematopoietic stem/progenitor and
lineage-committed cells and thereby enrich BMSCs from 3-
week-old long bone (Figure 4A). Next, we performed droplet-
based scRNA-seq using the 103 Genomics chromium system.
We obtained a total of 18,297 cells by combining two experi-
ments and, after trimming down doublets and residual hemato-
poietic cells, using bioinformatics (Figure S5A). Clustering and
t-distributed stochastic neighbor-embedding (t-SNE) identified
four cell clusters, as visualized in a color-coded t-SNE plot and
cluster-frequency graph (Figures 4B and S5B). Cluster-specific
marker genes were identified by analysis of pairwise differential
gene expression of each cluster against all other clusters. The
top six highly expressed genes for each cluster are displayed
in a heatmap (Figure 4C), and specific markers for each individ-
ual cluster are shown in violin plots (Figure 4D). Cell types were
identified based on the expression of a known marker combined
with newmarker genes, such as Pdgfrb and Cfh, encoding com-
plement component factor H, for BMSCs. Chondrocytes ex-
press Acan (encoding aggrecan) and Scrg1 (scrapie responsive
gene 1/stimulator of chondrogenesis 1). Endothelial cells ex-
press Cdh5 (encoding the cell adhesion molecule VE-cadherin)
and Emcn (a mucin-like sialoglycoprotein), whereas transcripts
for Pdgfrb,Myh11 (encoding SMC-specific myosin heavy chain),
and Acta2 (a-SMA) are found in vascular smooth muscle cells
(Figure S5C). Immunostaining of sections from 3-week-old femur
for endomucin, PDGFRb, and aggrecan followed by tile-scan
confocal imaging reveals the anatomical location of these major
cell populations (Figures 4E and S5D). Consistent with previous
studies, our scRNA-seq approach confirmed that the expression
of crucial niche factors for HSCs, namely Kitl (encoding stem cell
factor; SCF) and Cxcl12 (SDF-1), is found in Lepr+ BMSCs, spe-
cifically dpMSCs (Figures S5E). Kitl transcripts are also highly
enriched in Lepr+ dpMSCs/reticular cells, whereas Cxcl12 is
more broadly expressed and also found in chondrocytes,
SMCs, and some ECs.
Sub-clustering of BMSCs with Seurat (Butler et al., 2018) iden-
tified seven subpopulations with distinct gene expression and
substantial molecular heterogeneity (Figures 4F and S5F): BMSC
subclusters 1 and 2 represent Lepr+ Esm1+ diaphyseal BMSCs
(dpMSC1 and dpMSC2), which are distinguished by expression
of Serpina3f (serine protease inhibitor A3F) and Gdpd2 (glycero-(E–G) Tile scan confocal image of tamoxifen-treated Lepr-CreERT2 R26-mT/mGm
express the BMSCmarker PDGFRb (red, white arrowheads) and osterix (OSX, sm
cells; see bottom in (F) for highermagnification. Analysis of Lepr-CreERT2 R26-mT
the metaphysis (white arrowheads) into BM (yellow arrowheads) (G).
(H and I) Representative confocal image of young (3 weeks) and adult (12 weeks) w
increase of PLIN+ adipocytes (arrowheads) (I) with increased age (n = 6; data are
(J) Tile-scan confocal images showing strong increase of PLIN+ (red) adipocytes
See also Figures S3 and S4phosphoinositol inositolphosphodiesterase). Subcluster 3 defines
metaphysealmpMSCscharacterizedby transcription of the integ-
rin ligand periostin (Postn) and the Notch pathway gene Hey1.
BMSC sub-clusters 4 and 5 are osteoprogenitor cells (OPC1
and OPC2) expressing transcripts for the transcription factors
OSX (Sp7) and Runx2, osteocalcin-related protein (Bglap3), and
the alpha 1 chain of collagen XXII (Col22a1). Subcluster 6, ex-
pressing the surface protein CD109 and carbonic anhydrase 3
(Car3), represents differentiated osteoblasts (OBs). Proliferating
BMSCs (P-BMSCs) in subcluster 7 express Ki-67 (Mki67) and
DNA topoisomerase II alpha (Top2a) (Figures 4G and S5G–S5I).
We confirmed the identity of selected clusters with a combination
of reporter strains and immunostaining of bone sections. Expres-
sion of aHey1-GFP reporter allele marks PDGFRb+ mpMSCs and
OSX+ cells in 3-week-old mp but also PDGFRb+ vascular smooth
muscle cells (Figures S5J–S5L). Labeling of cells by Lepr-Cre-
controlled expression of tdTomato fluorescent protein in combi-
nation with ESM1 or PDGFRb immunostaining shows that
dpMSC1 and dpMSC2 are associated with the sinusoidal vascu-
lature inBM,whereas tdTomato+ cells in thempare largely devoid
of ESM1 and PDGFRb immunosignals (Figure S5M). Monocle tra-
jectory analysis of BMSC clusters places mpMSCs in the center,
with three direction paths toward P-BMSCs, dpMSC1 and
dpMSC2, and OPC1 and OPC2 cells, respectively (Figure 4H).
Relative geneexpression inpseudo-time further argues for a close
relationshipbetweenmpMSCsandosteoprogenitors/osteoblasts
but also dpMSCs/reticular cells (Figure 4I). Together, these data
indicate that the PDGFRb+ mpMSC population in bone contains
progenitors with the potential to generate major BMSC subsets.
Single-cell analysis of PDGFRb+ MSC lineage
differentiation
To gain further insight into BMSC differentiation in vivo, Pdgfrb-
CreERT2 Rosa26-mTmG (Pdgfrb-Cre R26-mT/mG) double-
transgenic mice were treated with tamoxifen at P1–P3 and
euthanized at P21 for the isolation of GFP+ cells from long
bone, followed by scRNA-seq analysis (Figures 5A and S6A).
This approach yielded 7,902 cells belonging to three major cell
populations, namely BMSCs (clusters 4, 5, and 7), chondrocytes
(clusters 1, 3, and 9), and SMCs (cluster 2), and two minor cell
populations, namely fibroblasts (FBs, cluster 8, Ly6a+, and
Cdh13+) and hematopoietic cells (HCs, cluster 9, Ctse+, and Tu-
ba4a+) (Figures 5B and S6B). Pdgfrb-Cre R26-mT/mG-
controlled expression of GFP transcripts was detectable in all
five cell populations, which also expressed the expected cell
type and subpopulation-specific marker genes (Figures 5C–5E,
S6B, and S6C). In addition, our data contain a minor population
of Cdh5+ ECs, which presumably represents a contamination
because of cell doublets or fragments (Figure S6C).ice analyzed at P4 and P21 (E). Higher magnification shows that GFP+ cells co-
all arrows). Yellow arrowheadsmark GFP+ cells in BM, which represent reticular
/mG lineage tracing at P27 and 8weeks uncovers expansion of GFP+ cells from
ild-type femur and graphs showing reduction of OSX+ osteoprogenitors (H) and
presented as mean ± SEM, p values, two-tailed unpaired t test).
after irradiation.
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OPEN ACCESSTrajectory analysis of Pdgfrb-Cre R26-mT/mG cells and rela-
tive gene expression in pseudo-time further support the genetic
lineage tracing results and argue that Pdgfrb+ BMSCs can un-
dergo osteogenic, chondrogenic, adipogenic, and smooth
muscle cell differentiation (Figures 5F, 5G, and S6D). Similarly,
culture of GFP+ BMSCs isolated from Pdgfrb-Cre R26-mT/mG
bone confirms the results obtained with sorted mpMSCs (Fig-
ures 2F–2J) and supports PDGFRb+ (GFP+) cells possessing
osteogenic, adipogenic, and chondrogenic differentiation poten-
tial in vitro (Figures S6E and S6F).
Function of PDGFRb+ BMSCs in bone formation
To determine the function of PDGFRb+ BMSCs in bone forma-
tion, we ablated this cell population with a genetic strategy using
a combination of Pdgfrb-CreERT2 and R26-DTAmice (Wu et al.,
2006), enabling tamoxifen-inducible, Cre-controlled expression
of diphtheria toxin (R26-DTAiDMSC). Double-transgenic pups
received tamoxifen at P6–P8 and were analyzed at P21 (Fig-
ure S7A). DTA-mediated ablation of PDGFRb+ cells leads to
decreased femur length (Figure S7B) and profound alterations
in the mp. The region containing columnar CD31hi Emcnhi (type
H) vessels, which has previously been shown to couple angio-
genesis and osteogenesis (Kusumbe et al., 2014), as well as
the number of OSX+ osteoprogenitors and deposition of the ma-
trix protein osteopontin, are strongly reduced in R26-DTAiDMSC
femur compared with Cre-negative littermate control samples
(Figures S7C andS7D).Microtomography (MicroCT) analysis un-
veils significant reduction of R26-DTAiDMSC trabecular bone vol-
ume and cb thickness (Figures S7E and S7F).
As previous reports have shown that PDGFRb signaling pro-
motes osteogenesis and triggers the activation of skeletal
stem and progenitor cells during bone repair (Böhm et al.,
2019; Xie et al., 2014), we used an inducible genetic approach
in mice to overexpress human PDGF-B, specifically in ECs
(see Method details; Figure 6A). In the resulting PDGF-B gain-
of-function mice, the area of the femoral mp, the length of
columnar type H vessels, the abundance of PDGFRb+ mpMSCs
and OSX+ osteoprogenitors, and the number of CD31+ EMCN
arteries are increased (Figures 6B–6D). Together, these results
indicate that signaling through PDGF-B and PDGFRb controls
key aspects of both osteogenesis and angiogenesis in postnatal
bone.
Extrinsic and intrinsic signals control BMSC lineage-
specific differentiation
Previous work has shown that CAR cells associated with BM si-
nusoidal vessels show adipocyte-like gene expression,Figure 4. Transcriptional landscape and heterogeneity of BMSCs at si
(A) Schematic overview of bone sample preparation for scRNA-seq.
(B–D) t-SNE plot with color-coded subclusters. Cell numbers are indicated for ea
clusters (C) and violin plots of individual cluster markers (D).
(E) Tile-scan confocal image of 3-week-old femur stained for EMCN (blue) PDGFR
smooth muscle cells covering arteries.
(F and G) t-SNE plot with color-coded BMSC subclusters (F). Expression of me
Runx2, and Bglap3), and proliferative (Mki67) marker genes in BMSC subcluster
(H and I) Monocle trajectory analysis of BMSC lineage differentiation. Clusters ar
displayed in pseudo-time (I).
See also Figure S5whereas cells that are enriched for osteo-lineage-related tran-
scripts preferentially localize to arterioles or non-vascular areas
(Baccin et al., 2020; Baryawno et al., 2019; Zhong et al., 2020).
In our single-cell analysis, dpMSCs also show pronounced
expression of adipocyte markers under baseline conditions
(Figure S7H). Genetic cell tracking and scRNA-seq results sup-
port BMSC specification being dynamically regulated, leading
to adipogenic differentiation after irradiation (Figures S4F,
S4G, S7G, S7H, and S8A). Cre-controlled overexpression of hu-
man PDGF-B in murine ECs in vivo (R26-PDGFBiEC), on the
other hand, boosts the abundance of PDGFRb+ mpMSCs and
dpMSCs. The number of osteogenic (OSX+) cells is also
increased, relative to littermate controls, whereas the number
of perilipin+ adipocytes in is significantly reduced in adult
R26-PDGFBiEC mice (Figures 6E–6I, S8B, and S8C). The
changes in postnatal R26-PDGFBiEC gain-of-function mutants
are accompanied by alterations in the long bone vasculature,
namely, increases in the length of vessel columns in the mp
and the number of arteries (Figures 6F and 6G). Taken together,
these results show that PDGF-B boosts the number of BMSCs
and promotes osteogenic differentiation, whereas adipocyte
formation is inhibited.
The AP-1 family transcription factor Jun-B (encoded by Junb)
is a key regulator of adipogenic and osteogenic differentiation
(Rauch et al., 2019). Junb is highly expressed in mpMSCs (Fig-
ure 7A). Immunostaining of bone sections shows that Jun-B pro-
tein is predominantly found in the mp, where the transcription
factor labels the nuclei of Pdgfra-GFP+, PDGFRb+, and Hey1-
GFP+ mpMSCs (Figures 7B, 7C, S8D, and S8E). To investigate
the function of Jun-B in those cells, animals generated by inter-
breeding of mice carrying a loxP-flanked Junb allele (Hess et al.,
2003) and the Pdgfrb-CreERT2 transgenic line were treated with
tamoxifen from P1–P3 and analyzed at P21 (Figure S8F). Inacti-
vation of Junb in PDGFRb+ cells results in the profound reduction
of the area covered by metaphyseal type H vessel columns and
of PDGFRa+ and PDGFRb+ cells relative to the control (Fig-
ure 7D). The number of OSX+ OPCs, type H vessel columns
and arteries are reduced in Junbmutant bone, whereas perilipin+
adipocytes are increased, relative to control littermates (Figures
7E, 7F, and S8GS8I). Furthermore, long bone longitudinal growth
and weight are also reduced in JunbiDMSC-mutant bone
compared with that of controls (Figures 7G, S8J, and S8K).
These data indicate that EC-derived PDGF-B acts as a critical
niche factor for BMSCs and promotes osteogenic differentiation
of these cells. The AP-1 family transcription factor Jun-B con-
trols BMSC fate and represses adipogenic differentiation during
bone development.ngle-cell resolution
ch cluster (B). Heatmap of the top-six most-significantly expressed genes in all
b+ (red) mark and ACAN (green, chondrocytes). Arrowheads indicate PDGFRb+
senchymal (Pdgfrb, Pdgfra, Lepr, and Esm1), osteogenic (Hey1, Sp7, Postn,
s (G).
e colored according to their identity (H) and relative expression of key genes is
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There is increasing evidence that BMSCs represent a heteroge-
nous mixture of different cell populations with distinct molecular
and functional properties (Baccin et al., 2020; Baryawno et al.,
2019; Tikhonova et al., 2019). This issue is further complicated
by the plasticity of BMSCs, which can enable the acquisition of
different terminal fates depending on external signals and stress
factors (Ambrosi et al., 2017; Cook and Genever, 2013; Tencer-
ova and Kassem, 2016). Given these complications, it has re-
mained unclear whether BMSC subsets are derived from several
different or a single (common) stem/progenitor population. Our
genetic fate mapping approach with tamoxifen-inducible
Pdgfrb-CreERT2, Lepr-CreERT2, and Gli1-CreERT2 lines ar-
gues that the mp harbors multipotent cells, which provide
several different stromal cell populations during development.
Shortly after tamoxifen administration, recombined BMSCs are
predominantly confined to the mp and represent vessel-associ-
ated PDGFRa+b+ mpMSCs. Furthermore, we provide evidence
that proliferation, colony-forming capacity, and multipotency
in vivo and ex vivo are primarily associated with PDGFRa+b+
Hey1+mpMSCs. This is also supported by the trajectory analysis
of our scRNA-seq data, which shows that proliferating BMSCs
emerge from mpMSCs but not from dpMSCs/reticular cells in
postnatal BM. Moreover, trajectory analysis and genetic fate
tracking indicate that mpMSCs have the capacity to generate
osteoblast lineage cells as well as dpMSCs.
Recently, scRNA-seq approaches were used to investigate
the composition of adult BM stroma (Baccin et al., 2020; Bar-
yawno et al., 2019; Tikhonova et al., 2019; Zhong et al., 2020).
Given their critical role in hematopoietic stem cell maintenance
and function, vessel-associated reticular (CAR) cells in the BM
were a focus of these studies. LepR+ CAR cells express high
levels of the chemokine CXCL12 and stem cell factor (SCF),
which are both important regulators of hematopoietic stem and
progenitor cells (HSPCs). In addition, LepR+ BMSCs contain
transcripts for adipogenic genes, which is consistent with their
ability to give rise to adipocytes in response to myeloablative
treatment and other challenges (Baryawno et al., 2019; Tikho-
nova et al., 2019). This population of LepR+ BMSCs might be
similar to adipo-CAR cells identified by Baccin et al. (2020) and
adipogenic lineage precursors (MALPs) reported by Zhong
et al. (2020). Based on the expression of Lepr, HSPC niche fac-
tors and adipogenic genes, these cells also appear to be equiv-
alent to the dpMSCs described in our study. We, therefore, pro-
pose that dpMSCs/reticular cells are derived from mpMSCs
under physiological conditions. It is feasible, however, that
mpMSCs and dpMSCs retain plasticity and might be intercon-
vertible in response to tissue damage, during regeneration orFigure 5. Single-cell analysis of PDGFRb+ bone cells
(A) Experimental strategy for scRNA-seq analysis of Pdgfrb-CreERT2-labeled (G
(B and C) t-SNE plot with color-coded cell clusters in scRNA-seq analysis of GF
muscle cells (SMCs), mpMSCs and dpMSCs, a small population of GFP+ hemato
plots showing GFP transcripts in all clusters and expression of cell-type-specific
(D and E) Heatmap displaying expression of selected cell-type-specificmark gene
(F and G) Monocle trajectory analysis of color-coded Pdgfrb-CreERT2-labeled c
See also Figure S6in the context of aging and disease. It also needs to be noted
that clonal analysis by in vivo transplantation would give more-
direct and -conclusive evidence for the multipotent nature of
mpMSCs and their differentiation potential.
Several previous publications have made use of genetic ap-
proaches and fluorescence-activated cell sorting (FACS) isola-
tion strategies to study the nature and spatial distribution of
MSPC/SSCs. This has, for example, established that lineage-
restricted stem and progenitor cells give rise to bone, cartilage,
and stromal tissue in a clonal fashion preferentially around the
femoral growth plate but do not generate hematopoietic, adi-
pose, or muscle cells under normal conditions (Chan et al.,
2015). Arguing further for the enrichment of MSPC/SSCs in the
mp, similar to what we have observed in our study, cells labeled
with a tamoxifen-inducible Col2–CreER (Col2a1-CreERT2) allele
continued to generate osteoblasts and stromal cells in the mp
and epiphysis in addition to chondrocytes in the growth plate
and articular cartilage for more than a year. Because the same
approach did not mark BMSCs in the middle of the diaphysis, it
was proposed that those cells might be derived from a separate
population of LepR+ precursor cells (Nakamura et al., 2006; Zhou
et al., 2014). That notion is not, however, fully consistent with our
new data indicating that Lepr-CreERT2-labeled cells emerge
initially in the mp before they populate the postnatal BM. Adding
further complexity, several studies have also identified the peri-
osteumasasourceof SSCswith highbone regenerative capacity
(Debnath et al., 2018; Duchamp de Lageneste et al., 2018). Thus,
future studies will have to compare the molecular profiles and
functional properties of putative MSPC/SSCs from different
bone regions, including the mp, diaphysis, and periosteum.
In addition to insight on the localization and maintenance of
MSPC/SSCs, it is also important to understand the regulators
controlling the differentiation and lineage specification of those
cells. The analysis of global knockout mice has previously es-
tablished that the transcription factor Jun-B is necessary for
stromal cell proliferation and differentiation into bone-forming
cells (Hess et al., 2003; Kenner et al., 2004). Indeed, we also
found that cell-type-specific JunbiDMSC mutants, generated
with the Pdgfrb-CreERT2 line, have strongly impaired bone
growth and a significant reduction of OSX+ OPCs, whereas
the number of perilipin+ adipocytes is increased. These results
indicate that Jun-B controls the behavior of PDGFRb+ BMSCs,
presumably mpMSCs, which indirectly also affects the bone
vasculature. These results highlight the cell-autonomous func-
tion of Jun-B in BMSCs but also the extensive crosstalk
between vessel-associated cells and the adjacent endothelium.
Blood vessels are known to be an important source of PDGF-B,
which promotes the proliferation and recruitment of PDGFRb+
pericytes and vascular smooth muscle cells (Hellström et al.,FP+) cells.
P+ cells. Clusters represent chondrocytes (CHO1, CHO2, and CHO3), smooth
poietic cells (HCs), osteoblastic cells (OBs), and fibroblasts (FBs) (B). Feature
marker genes (green) (C).
s (D). Violin plots showing expression of selectedmarkers in cell subclusters (E).
lusters (F). Differentiation pathway of each cell cluster (G).
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Figure 6. Effect of endothelial-cell-derived PDGF-B on BMSC differentiation in bone
(A) Scheme of tamoxifen-inducible PDGFB overexpression in ECs with Cdh5-Cre-ERT2 mice.
(B) Representative confocal image of 3-week-old control and R26-PDGFBiEC femoral EMCN+ (red) blood vessels associated with PDGFRb+ (green) BMSCs
(arrowheads). Length of metaphyseal vessel columns (indicated by dashed lines) is increased inR26-PDGFBiEC bone (n = 4; data are presented asmean ±SEM, p
values, two-tailed unpaired t test).
(C) Expansion of EMCNhigh (red) CD31high (green) vessels (indicated by dashed lines) and increase of arterioles (arrowheads) in R26-PDGFBiEC bone (n = 4; data
are presented as mean ± SEM, p values, two-tailed unpaired t test).
(D) Confocal image and quantitation showing increase of OSX+ (green) cells in PDGFBiEC bone (n = 4; data are presented as mean ± SEM, p values, two-tailed
unpaired t test).
(E) Tamoxifen-inducible overexpression of human PDGF-B (PDGFB) in ECs.
(F andG) Representative confocal images and quantitative analysis of 8-week-oldR26-PDGFBiEC femur showing increase in PDGFRb+mpMSCs (F), arrowheads)
and arterioles (G), arrowheads) relative to control (n = 4; data are presented as mean ± SEM, p values, two-tailed unpaired t test).
(H and I) Representative confocal images showing increased OSX+ cells (H) and decrease of PLIN+ adipocytes (arrowheads) (I) in 8-week-old R26-PDGFBiEC
femur relative to control (n = 4; data are presented as mean ± SEM, p values, two-tailed unpaired t test).
See also Figures S7 and S8




Figure 7. Function of Jun-B in PDGFRb+ BMSCs in vivo
(A) Junb transcripts in mpMSCs relative to dpMSCs (n = 3–4; Fpkm, fragments per kilobase million; data are presented as mean ± SEM, p values, two-tailed
unpaired t test).
(B and C) 3-week-old Pdgfra-GFP (green) femur immunostained for Jun-B (red) and PDGFRb (blue) (B). Higher magnification confirms Jun-B expression in
Pdgfrb-GFP+ PDGFRb+ mpMSCs (arrowheads) (C).
(D) Maximum-intensity projection shows the reduction of PDGFRb+ (top) and PDGFRa+ (bottom) cells (arrowheads) associated withmetaphyseal vessel columns
(indicated by dashed lines) near the growth plate in 3-week-old Junb iDMSC bone.
(E) Decrease of OSX+ (green, arrowhead) cells in 3-week-old Junb iDMSC metaphysis (n = 5; data are presented as mean ± SEM, p values, two-tailed unpaired t
test).
(F) Representative confocal images and quantitation showing increase of PLIN+ adipocytes in Junb iDMSC epiphysis andmetaphysis relative to control (n = 5; data
are presented as mean ± SEM, p values, two-tailed unpaired t test).
(G) Image of control and Junb iDMSC mutant femurs. Femur length is significantly reduced after inactivation of Junb. (n = 6; data are presented as mean ± SEM, p
values, two-tailed unpaired t test).
See also Figures S7 and S8
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OPEN ACCESS1999). In bone, PDGFRb controls the behavior of skeletal stem
and progenitor cells during regeneration (Böhm et al., 2019;
Doherty et al., 2019). In agreement with these results, we
show that overexpression of PDGF-B enhances the number ofOSX+ OPCs, suppresses the emergence perilipin+ adipocytes,
and promotes type-H vessel and artery formation in the bone
vasculature. Together, these data establish that BMSC fate is
controlled by a combination of cell-autonomous and extrinsicCell Reports 36, 109352, July 13, 2021 13
Article
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OPEN ACCESSsignals, with implications for vascular growth and, thereby, the
communication between different cell types in bone. Given the
great relevance of BMSCs for biotechnology and the develop-
ment or therapeutic approaches aiming at improved fracture
healing, future work might well gain important insights from
our analysis of postnatal bone BMSCs. Some findings might
also be relevant in the context of osteoporosis and other dis-
eases characterized by impaired bone formation (Aghebati-Mal-
eki et al., 2019; Hu et al., 2018).
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Wirth, A., Benyó, Z., Lukasova, M., Leutgeb, B., Wettschureck, N., Gorbey, S.,
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muscle actin (Cy3 - conjugated)
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iScript cDNA Synthesis kit BIO-RAD Cat# 1708890
TaqMan Gene Expression Master Mix ThermoFisher Scientific Cat#4369016




High sensitive DNA kit Agilent Bioanalyzer Cat#5067-4626
Chromium Single cell 30 Reagent Kit v2 10X genomics Cat#PN-120237
NextSeq 500/550 High Output Kit V2 (150
cycles)
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NextSeq 500/550 Mid Output Kit V2 llumina Cat#20024904
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Leprtm2(cre)Rck/J The Jackson Laboratory JAX:008320
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Data and code availability
The NGS datasets (bulk-RNA and single cell -RNA sequencing) used in this article are available at GEO (https://www.ncbi.nlm.nih.
gov/geo/) with the accession number GEO: GSE156636.
EXPERIMENTAL MODELS AND SUBJECT DETAILS
Animal models
C57BL/6J male mice were used for all analysis of wild-type bone. Pdgfra-GFP heterozygous knock-in, Sp7-mcherry and Cspg4-
DsRed reporter mice were used for MSC characterization. Pdgfra-GFP and Sp7-mcherry mice were crossed to generate double
transgenic reporter mice. Hey1-GFP (Tg(Hey1-EGFP)ID40Gsat) (http://www.gensat.org) heterozygotes were used for analysis of
mpMSCs from bone. For the characterization of MSC differentiation and lineage tracing, Pdgfrb-CreERT2 (Chen et al., 2016),
Myh11-CreERT2 (Wirth et al., 2008), Gli1-CreERT2 (Ahn and Joyner, 2004), Lepr-Cre (DeFalco et al., 2001) and Lepr-CreERT2
(see below) transgenic mice were interbred with Gt(Rosa26) ACTB-tdTomato-EGFP reporter mice (Muzumdar et al., 2007) or
Gt(Rosa26)–dTomato (Madisen et al., 2010) reporter mice, respectively. Double transgenic offspring (R26-DTAiDMSC) generated by
interbreeding ofPdgfrb-CreERT2 andR26-iDTA (Wu et al., 2006) micewas used for tamoxifen-inducible cell ablation. To overexpress
PDGF-B in endothelial cells, we interbred R26-hPDGFB (Armulik et al., 2010) and Cdh5-CreERT2 mice (Sivaraj et al., 2020). Junb
floxed mice (Kenner et al., 2004) were bred to Pdgfrb-CreERT2 transgenic animals for conditional inactivation of Junb in MSCs.
Cre positive (JunbiDMSC or R26-DTAiDMSC) mutants were compared to Cre negative control littermates.
For the generation of Lepr-CreERT2 transgenic mice, a cDNA encoding tamoxifen-inducible Cre recombinase (CreERT2) followed
by a polyadenylation signal sequence and an FRT-flanked ampicillin resistance cassette was introduced by recombineering into the
start codon of Lepr in the BAC clone RP23-135C17 (BACPAC Resources Center, Children’s Hospital Oakland Research Institute,
Oakland, USA). After Flp-mediated excision of the ampicillin resistance cassette in bacteria, the resulting constructs were validated
by PCR analysis and used for pronuclear injection into fertilized mouse oocytes. Founders, identified by PCR genotyping, were bred
to Cre-mediated reporter transgenic Rosa26-mT/mG mice.
For inducible Cre-mediated recombination, pups received daily intraperitoneal injections (IP) of 50 mg or 100 mg of tamoxifen from
postnatal day 1 (P1) to P3 or from P22 to P24. Tamoxifen stocks were prepared by dissolving 20mg in 500 mL of ethanol and vortex for
10mins before an equal volume of Kolliphor EL was added. 1mg aliquots were stored at20C and dissolved in the required volume
of PBS prior to injection (Sivaraj et al., 2020).
Age or developmental stage of themice used are indicated in the text and figures. All husbandry and experiments involving animals
were performed in compliance with the relevant laws and institutional guidelines, following protocols previously approved by local
animal ethics committees and conducted with permission granted by the Landesamt f€ur Natur, Umwelt und Verbraucherschutz (LA-
NUV) of North Rhine-Westfalia to the Max Planck Institute of Molecular Biomedicine. Our research fully complies with national and
international standards for animal husbandry, welfare, and monitoring as well as the 3Rs (replacement, reduction, and refinement).
BMSC isolation and culture
Femur and tibia were harvested from 3-week-old mice, surrounding muscle tissue was cleaned off and the epiphysis removed. The
metaphysis was separated with a scalpel to obtain metaphyseal BMSCs (mpMSCs). Next, bone marrow was gently removed from
the bone shaft into suspension medium (1% FBS, 1mM EDTA in PBS without Ca2+/Mg2+) to obtain BM-derived BMSCs (dpMSCs).
Metaphyseal fragments were cut into small pieces and crushed usingmortar and pestle. Crushed samples were digested using 1mL
of Collagenase type II and I enzymes (2mg/ml) for 20mins at 37C under gentle agitation. Digestedmetaphysis and BM samples were
transferred through 70 mm strainers into 50ml tubes to obtain single–cell suspensions, which were resuspended in suspension me-
dium, centrifuged at 300 g for 5mins, and washed 2 to 3 times. Cell pellets were resuspended in the respective volume of suspension
medium. Next, we used lineage cell depletion kit (Milteyi Biotec, cat#130-090-858) to deplete hematopoietic cells. BMSCs were
isolated fromPdgfra-GFP orHey1-GFP reportermice by using FACS. Sorted cells were collected inMesenCult MSCmedium (STEM-
CELLTM Technology. Cat#05501,05502). BMSCs were cultured in MesenCult BMSC medium, maintained with 5% CO2 in a water-
jacketed incubator at 37C. Half of the medium was changed weekly.
METHOD DETAILS
Bone sample preparation and immunofluorescence staining
Micewere euthanized and long bones (femur and tibia) were harvested and fixed immediately in ice-cold 2%paraformaldehyde (PFA)
for 6 to 8 hours under gentle agitation. Bones were decalcified in 0.5M EDTA for 16 to 24 hours (for samples from 3-week-old animals)
or 2-3 days (adult samples) at 4C under agitation, which was followed by overnight incubation in sucrose solution (20% sucrose, 2%
PVP) and immersion in bone embedding (8%gelatine, 20% sucrose, 2%PVP). Samples were stored overnight at80C. 60-100 mm-
thick cryosections were prepared for immunofluorescence staining (Kusumbe et al., 2015).Cell Reports 36, 109352, July 13, 2021 e3
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ice-cold PBS and permeabilized with ice-cold 0.3% Triton X-100 in PBS for 10 mins at room temperature (RT). Samples were incu-
bated in blocking solution (5% heat-inactivated donkey serum in 0.3% Triton X-100) for 30mins at RT. Primary antibodies (see Key
resources table) were diluted in 5% donkey serum and PBS and incubated overnight at 4C. Next, slides were washed 3 to 5 times in
PBS in 5-10min intervals. Species-specific Alexa Fluor secondary antibodies (ThermoFisher) diluted in PBS were added and incu-
bated for 2-3 hours at RT.
Electron microscopy (EM)
Femurs of 3 weeks old mouse were removed and cut directly longitudinally into half in fixative, containing 2% glutaraldehyde, 2%
paraformaldehyde, 20mMCaCl2, 20mMMgCl2 in 0,1M cacodylatbuffer, pH 7.4. The samples were fixed for 3 hours at room temper-
ature. For post-fixation, specimen was incubated in 1%OsmO4, containing 1.5%KFeCN in 0.1M cacodylate buffer, pH 7.4, followed
by stepwise dehydration, uranyl-en-bloc staining and epon embedding. Ultrathin sections were cut from the area of interest and
brought on formvar-filmed single-slot grids. Sections were counterstained with lead citrate and analyzed at a transmission electron
microscope at 80kV (Tecnai-12-biotwin, Thermo-Fisher, Eindhoven, Netherlands). Representative imageswere takenwith a 2K-CCD
camera (Veleta, EMSIS, Muenster, Germany).
MSC CFU-F and differentiation assay
For colony formation assays, mpMSCs or dpMSCs were freshly isolated from Hey1-GFP or Pdgfra-GFP reporter mice. Single cell
suspensions (1000 cells per cm2) were plated and incubated at 37C under 5% hypoxia conditions for 14 days with MesenCult
MSC medium. Half of the medium was changed after a week. 14 days later, cells were fixed, stained, and number of colonies
counted.
To analyze osteogenic, adipogenic, and chondrogenic differentiation, mpMSCs were cultured in 6 well plates with MesenCult me-
dium. At 50 – 70% confluency the culture medium was replaced with differentiation medium (R&D system, base medium
cat#CCM007, osteogenic supplement cat#CCM009 and adipogenic cat#CCM011; Chondrogenic differentiation medium
cat#CCM005 and supplement cat#CCM006). After 2 – 3 days the medium was replaced once and after 15 days cells were analyzed
for differentiation by immunostaining and quantitative PCR.
Quantitative PCR (qPCR)
Total RNA was isolated from BMSCs or BMSC-derived cells using RNA Plus mini kit (QIAGEN, Cat#74134) according to the manu-
facturer’s instructions. RNA was reverse-transcribed using the iScript cDNA synthesis kit (Bio-Rad, Cat#1708890). Quantitative PCR
was carried out using gene specific Taqman probes (see Key resources table) using C1000 Touch Thermal cycler (BIORAD).
Fluorescence activated cell sorting (FACS)
Single cell suspensions were prepared from 3-weeks-old Hey1-GFP, Pdgfra-H2B-GFP, PdgfrbCre Rosa26mT/mG reporter mice fe-
mur and tibia as described above. DAPI was added and the incubation continued for 10mins on ice. Next, samples were washed 2-3
timeswith blocking solution and resuspended using ice-cold PBS. Cell sorting was performed on a FACSAria II cell sorter (BDBiosci-
ence). Dead cells and debris were excluded by FSC, SSC and DAPI positive signal. Sorted GFP were collected in blocking buffer for
scRNA-seq or RTL buffer for bulk RNA-seq or MSC cell culture medium.
Bulk-RNA sequencing and data analysis
Metaphyseal and diaphyseal BMSCs were sorted from three weeks old Hey1-GFP metaphysis and Pdgfra-EGFP BM using a flow
cytometer. RNA was isolated using the RNeasy Plus Micro Kit (QIAGEN) according to the manufacturer’s instructions. RNA quality
was checked using a 2100 BioAnalyzer (Agilent). 10ng of RNA were used for preparation of sequencing libraries with SMARTer Ultra
Low input RNA Kit-V3 (Clontech laboratories) and followed by Nextera XT DANN Library Prep Kit (Illumina) according to the manu-
facturer’s instructions. Libraries were validated using a BioAnalyzer, quantified by qPCR and Qubit Fluorometric Quantitation
(Thermo Fisher). Libraries were diluted to a final concentration of 1.6pM for sequencing. The NextSeq 500/550 Mid Output Kit
v2.5 (Illumina) was used for sequencing with a NextSeq 500 (Illumina).
Bulk-RNA sequencing data analysis was performed as described previously (Sivaraj et al., 2020) with some modifications. The
quality assessment of raw sequence data was performed using FastQC (Version: FastQC 0.11.3). Paired-end sequence reads
were mapped to the mm10 mouse genome assembly (GRCm38) using TopHat-2 (Version: tophat-2.0.13). The mouse genome
was downloaded from the iGenome portal. HTSeq was used to count the aligned reads on a per gene basis (Version: HTSeq-0.6.1).
The count data were normalized using the Variance Stabilizing Transformation (VST) function from the DESeq2 package. Principal
Component Analysis (PCA) was performed on transformed read counts using the variable genes to assess the overall similarity be-
tween the samples. Differential gene expression analysis between control and mutants were performed using DESeq2. Differentially
expressed genes were selected using an FRD-adjusted p value cut-off < 0.01 and an absolute log2 fold change > 0.5. Gene symbols
were annotated using biomaRt (BioConductor version 3.1). Gene ontology analysis and cellular signaling pathways were performed
with PANTHER online tool (http://www.pantherdb.org/).e4 Cell Reports 36, 109352, July 13, 2021
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3-week-old (n = 2) male mice were used for non-hematopoietic single cell analysis. Femur and tibia were harvested, cleaned from
attached surrounding tissue and collected in ice cold sterile PBS (without Ca2+/Mg2+). Next, bones were cut into small pieces and
crushed using mortar and pestle. Samples were digested using 1 mL of collagenase type II and I enzymes (2mg/ml) for 20mins at
37C under gentle agitation. Digested samples were transferred to 70 mm strainers in 50ml tubes to obtain a single–cell suspension,
which was resuspended in blocking solution (1% BSA, 1mM EDTA in PBS without Ca2+/Mg2+), centrifuged at 300 g for 5mins,
washed 2 to 3 times with ice-cold blocking solution, and filtered through 50 mm strainers. Pellets were resuspended in the equivalent
volume of blocking solution. To enrich bonemarrow stromal cells, hematopoietic cells were removed using a lineage cell depletion kit
(MACS, cat#130-090-858) following themanufacturer’s instructions. Next, lineage negative cells were depleted by CD45 and CD117
using microbeads (MACS, cat. no. 130-052-301 and 130-091-224) from lineage negative (lin-) bone cells. Bone marrow stromal cells
were examined by microscopy and resuspended at 106 cells/ml in 0.05% BSA in PBS.
For Pdgfrb-CreERT2 Rosa26-mT/mG reporter mice (n = 4), bone single cell suspension was prepared and lineage-positive cells
were depleted as described above. GFP positive cells were sorted by FACS Aria II (BD Bioscience), collected in blocking buffer
and used for scRNA sequencing.
Bone marrow stromal single cells or Pdgfrb-CreERT2 GFP+ sorted cells were prepared for microfluidic droplets-based scRNA-
seq. Single cells were encapsulated into emulsion droplets using Chromium controller (10X Genomics). The scRNA seq libraries
were prepared using the chromium single cells 30 regent kit (V2) (10X genomics, cat#PN-120237) according to the manufacturer’s
protocol. scRNA-seq libraries were evaluated and quantified by Agilent Bioanalyzer using High sensitivity DNA kit (cat#5067-
4626) and Qubit (ThermoFisher, car#Q32851). Individual libraries were diluted to 4nM and pooled for sequencing. Pooled libraries
were sequenced by High Output kit (150 cycle) (Illumina cat#20024907) with Next500/550 sequencer (Illumina).
Single cell RNA sequencing (scRNA-seq) analysis
Sequencing data were processed with UMI-tools (Smith et al., 2017) (version 1.0.0), aligned to the mouse reference genome (mm10)
with STAR (Dobin et al., 2013) (version 2.7.1a), and quantified with Subread featureCounts (Liao et al., 2014) (version 1.6.4). Data
normalization, cell clustering and visualization were performed using Seurat (Butler et al., 2018) (version 2.3.4, version 3.1.1). For
initial quality control of the extracted gene-cell matrices, we filtered cells with parameters low.threshold = 1,000, high.threshold =
6,000 for number of genes per cell (nGene), high.threshold = 0.3 for percentage of mitochondrial genes (percent.mito) and genes
with parameter min.cell = 3. Filtered matrices were normalized by LogNormalize method with scale factor = 10,000. Variable genes
were foundwith parameters ofmean.function = ExpMean, dispersion.function = LogVMR, x.low.cutoff = 0.0125, x.high.cutoff = 3 and
y.cutoff = 0.5, trimmed for the genes related to cell cycle (GO:0007049) and then used for principal component analysis. Statistically
significant principal components were determined by JackStraw method and the first 12 principle components were used for non-
linear dimensional reduction (tSNE), canonical correlation analysis (CCA) and clustering analysis with resolution = 0.4.Monocle (Trap-
nell et al., 2014) (version 2.10.1) was used for pseudotime trajectory analysis. We imported Seurat objects toMonocle R package and
then performed dimensionality reduction with DDRTree method with parameters max_components = 2 and norm_method = ’’log.’’
Cell cycle phaseswere classified by cyclone function of scran (Lun et al., 2016) (version 1.14.5). Detailed scripts and parameters used
for the study are available from the authors upon reasonable request.
Micro computed tomography (mCT) analysis
Femurs were fixed overnight in 4% PFA at 4C and analyzed using mCT. Measurements were carried out by Scanco Medical AG,
Switzerland. The chosen voxel size was 6 mm in all three spatial dimensions. For each sample, 248 slices were evaluated with the
following specifications: covering a total of 1.488 mm, X-ray voltage was 70 kVp, Intensity 114 mA, Integration Time 300 ms, Frame
Averaging 4.
QUANTIFICATION AND STATISTICAL ANALYSIS
Immunofluorescence stained bone sections were imaged with a Leica SP8 and ZEISS LSM 880 confocal microscope. Images were
analyzed, quantified, and processed using Volocity (Perkin Elmer), Adobe CS6 Photoshop and Illustrator software.
Statistical analysis was performed using Graphpad Prism software or the R statistical environment (http://www.r-project.org). All
data are presented as mean ± s.e.m. unless indicated otherwise. Unpaired two tailed Student’s t tests were used to determine sta-
tistical significance. p < 0.05 was considered significant unless stated otherwise. Sample number was chosen based on experience
from previous experiments. Reproducibility was ensured by several independent experiments. No animals were excluded from
analysis.Cell Reports 36, 109352, July 13, 2021 e5
